Home » Topics » BioWorld Science

BioWorld Science
RSS

MycoTox's antifungal program advances

Jan. 9, 1998

Ares-Serono's recombinant IFN-beta1a recommended for approval by CPMP for MS

Jan. 9, 1998

Serotone introduced in China

Jan. 9, 1998

Beaufour Ipsen to market Tanabe ACE inhibitor

Jan. 9, 1998

Second-generation CMV retinitis compound enters phase I/II

Jan. 9, 1998

Cell Therapeutics and City of Hope join forces for diabetes research

Jan. 9, 1998

Barr receives additional generic approval

Jan. 9, 1998

CNS-5161 shows efficacy in phase I trial

Jan. 9, 1998

Company Profile: PolyMASC

Jan. 9, 1998

Vical receives patent protection for lipid-mediated DNA vaccines

Jan. 8, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Beone eyes Huahui Health’s trispecific HH-160 with $2B option deal
BioWorld
Beone Medicines Ltd. gained an exclusive option to develop cancer immunotherapy HH-160 worldwide in a deal potentially worth more than $2 billion for Huahui...
Unique trial strategy muddies the ODAC waters for camizestrant
BioWorld
Following a discussion that focused more on a new personalized trial strategy rather than the proposed therapy, the U.S. FDA’s Oncologic Drugs Advisory Committee...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...